Cochrane Database Syst Rev. 2003;(4):CD000145.
Interventions for nausea and vomiting in early pregnancy.
Jewell D, Young G.
Division of Primary Health Care, University of Bristol, Cotham House,
Cotham Hill, Bristol, UK, BS6 6JL. david.jewell@bristol. Ac.uk
Background:
Nausea and vomiting are the most common symptoms experienced
in early pregnancy, with nausea affecting between 70 and 85% of women.
About half of pregnant women experience vomiting.
Objectives:
To assess
the effects of different methods of treating nausea and vomiting in
early pregnancy.
Search Strategy:
We searched the Cochrane Pregnancy and
Childbirth Group trials register (December 2002) and the Cochrane
Central Register of Controlled Trials (The Cochrane Library, Issue 4,
2002).
Selection Criteria:
Randomised trials of any treatment for nausea
and/or vomiting in early pregnancy. DATA COLLECTION AND ANALYSIS: Two
reviewers assessed the trial quality and extracted the data
independently.
Main Results:
Twenty-eight trials met the inclusion
criteria. For milder degrees of nausea and vomiting, 21 trials were
included. These trials were of variable quality. Nausea treatments were:
different antihistamine medications, vitamin B6 (pyridoxine), the
combination tablet Debendox (Bendectin), P6 acupressure and ginger. For
hyperemesis gravidarum, seven trials were identified testing treatments
with oral ginger root extract, oral or injected corticosteroids or
injected adrenocorticotropic hormone (ACTH), intravenous diazepam and
acupuncture. Based on 12 trials, there was an overall reduction in
nausea from anti-emetic medication (odds ratio 0.16, 95% confidence
interval 0.08 to 0.33). REVIEWER'S
Conclusions:
Anti-emetic medication
appears to reduce the frequency of nausea in early pregnancy. There is
some evidence of adverse effects, but there is very little information
on effects on fetal outcomes from randomised controlled trials. Of newer
treatments, pyridoxine (vitamin B6) appears to be more effective in
reducing the severity of nausea. The results from trials of P6
acupressure are equivocal. No trials of treatments for hyperemesis
gravidarum show any evidence of benefit. Evidence from observational
studies suggests no evidence of teratogenicity from any of these
treatments.